Article
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis.
Cancer discovery - 2 Dec 2024
Ben-Crentsil Nana Adjoa, Mohammed Ismail Wazim, Balasis Maria E, Newman Hannah, Quintana Ariel, Binder Moritz, Kruer Traci, Neupane Surendra, Ferrall-Fairbanks Meghan C, Fernandez Jenna, Lasho Terra L, Finke Christy M, Ibrahim Mohammed L, McGraw Kathy L, Wysota Michael, Aldrich Amy L, Ryder Christopher B, Letson Christopher T, Traina Joshua, McLemore Amy F, Droin Nathalie, Shastri Aditi, Yun Seongseok, Solary Eric, Sallman David A, Beg Amer A, Ma Li, Gaspar-Maia Alexandre, Patnaik Mrinal M, Padron Eric
Abstract excerpt
SIGNIFICANCE: This work identifies MALAT1 as a requisite downstream effector of oncogenic feedforward inflammatory circuits necessary for the development of TET2-mutated CH and fulminant myeloid malignancy. We elucidate a novel mechanism by which MALAT1 "shields" p65 from dephosphorylation to potentiate this circuit and nominate MALAT1 inhibition as a future therapeutic strategy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
